Bioatla Banner Image


  • Ticker BCAB
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Bioatla Logo Image
  • 51-200 Employees
  • Based in San Diego, California
BioAtla is a protein therapeutic company that uses discovery and evolution to develop safer and more potent drugs for the treatment of cancer. The culmination of their discovery and evolution expertise and more than 150 issued patents and patent applications is their Conditionally Active Biologics (CAB) platform, whereby monoclonal antibodies or other biologics can be engineered for selectiveMore conditional activation, for example preferential binding under the unique conditions of the tumor microenvironment. This improvement in tumor selectivity helps address the issue of on-target toxicity and improve therapeutic index. BioAtla is applying these technologies in their own pipeline and in partnerships to ultimately deliver better immunotherapies for cancer.

Most Recent Annual Report

MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Bioatla Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!